Recent news on Naropin

Ion channel specialist receives innovation award  -  May 17, 2007
LabTechnologist.com,One example is AstraZeneca's and Abraxis BioScience's marketed pain medication, Naropin (ropivacaine), is a calcium channel blocker that carries a FDA

FDA Safety Changes: Keppra, Naropin, Rebetol  -  Dec 22, 2006
Medscape (subscription)On August 8, the FDA approved safety label changes for ropivacaine HCl injection (Naropin, made by Abraxis BioScience, Inc) to warn of the rare risk for

FDA Safety Changes: Keppra, Naropin, Rebetol  -  Dec 22, 2006
Medscape (subscription)On August 8, the FDA approved safety label changes for ropivacaine HCl injection (Naropin, made by Abraxis BioScience, Inc) to warn of the rare risk for

Abraxis Completes AstraZeneca Products Buy  Jun 29, 2006
Products in this acquisition encompass over 100 dosage forms and include the leading branded anesthetic agent, Diprivan, and Naropin, as well as a ... -International News Service

Abraxis BioScience Completes Acquisition Of US Branded Anesthetic ...  Jun 28, 2006
...under the US branded anesthetic and analgesic product portfolios include Xylocaine, Polocaine, Nesacaine, Astramorph, Sensorcaine, Diprivan, Naropin, and EMLA ... -Trading Markets

Abraxis BioScience Completes Acquisition of the AstraZeneca US ...  Jun 29, 2006
...in this acquisition encompass over 100 dosage forms and include the leading branded anesthetic agent, Diprivan(R) (propofol), and Naropin(R) (ropivacaine), as ... -dBusinessNews Los Angeles



Abraxis BioScience Announces Co-Promotion Agreement with ...  Apr 26, 2006
These products encompass over 100 dosage forms and includethe leading branded anesthetic agent, Diprivan(R) (propofol), and aproprietary Naropin(R) (ropivacaine ... - Finanzen.net

Abraxis BioScience Announces Co-Promotion Agreement with ...  Apr 27, 2006
...products encompass over 100 dosage forms and include the leading branded anesthetic agent, Diprivan(R) (propofol), and a proprietary Naropin(R) (ropivacaine ... - PharmaLive.com

AstraZeneca makes $200M deal with Abraxis  Apr 27, 2006
Abraxis BioScience is buying AstraZeneca's US branded anesthetics and analgesic products including Xylocaine, Polocaine, Naropin, Nesacaine, Sensorcaine ... - BusinessWeek

AstraZeneca and Abraxis exchange drug programs  Apr 28, 2006
...products acquired by Abraxis encompass over 100 dosage forms and include the leading branded anesthetic agent, Diprivan, and a proprietary Naropin, as well as ... - Pharmaceutical Business Review

Astrazeneca and Abraxis Bioscience to Co-promote Cancer Therapy ...  Apr 27, 2006
The products covered by the agreement (Xylocaine, Polocaine, Naropin, Nesacaine, Sensorcaine, Astramorph, Emla Cream, and Diprivan) had US sales of ... - PharmaLive.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional